How Risky if China Moves Away from Its Zero-COVID Policy?

Ji-Ming Chen; Guo-Hui Li; Yu-Fei Ji; Ming-Hui Sun; Huan-Yu Gong; Rui-Xu Chen; Ji-Wang Chen

doi:10.20944/preprints202204.0185.v2

Preprint Hypothesis Version 2 Preserved in Portico This version is not peer-reviewed

Version 1 : Received: 20 April 2022 / Approved: 20 April 2022 / Online: 20 April 2022 (08:24:20 CEST)
Version 2 : Received: 23 April 2022 / Approved: 25 April 2022 / Online: 25 April 2022 (03:30:28 CEST)
Version 3 : Received: 5 May 2022 / Approved: 6 May 2022 / Online: 6 May 2022 (03:38:30 CEST)

We found four striking differences in the COVID-19 case fatality rate (CFR). All of these striking differences suggest that, besides vaccination, good isolation of cases, disinfection of their living environments, and maintenance treatment (IDM) are highly effective is in mitigating COVID-19. This suggestion is crucial to the global control of the pandemic and consistent with the theoretical functions of IDM in minimizing co-infections with various other pathogens and maintaining human body functions. Accordingly, the risk for China to move away from its zero-COVID policy shall depend on China’s control measures. The CFR of COVID-19 in China can remain less than one tenth of that of influenza, namely that COVID-19 can remain “tiny influenza” in China, if the IDM measures are well implemented (e.g., staying at well-disinfected home with good rest for vast mild cases). Otherwise, the CFR of COVID-19 in China can be several times higher than that of influenza, namely that COVID-19 can be “giant influenza” in China. This analysis also clarifies that the COVID-19 CFR shall increase greatly if many asymptomatic or mild COVD cases are isolated together at temporary hospitals.

COVID-19; case fatality rate; risk; co-infection; control; policy; pandemic

MEDICINE & PHARMACOLOGY, General Medical Research

Comment 1

Received: 25 April 2022
Commenter: Ji-Ming Chen
Commenter's Conflict of Interests: Author

Comment: Compared with version 1, this new version shares the same first affiliation (a company). I did submit a version using a university as the first affiliation, but this submission was withdrawn before version 1 and has never been published. This new version keeps the same conclusions, but Table 2 was revised and the data of Shanghai was revised from a ratio to the CFR with different data. All data and sentences were proofed throughout. I will not submit any new version for this manuscript which has been under review in a leading journal for weeks. Please publish this version as a new version, rather than replacing version 1 (the first affiliation of these two versions is the same company).

+ Respond to this comment

Your full name

Your affiliation information (e.g., name of your university/institution/organization)

Not displayed online.

Your Email address (not made public)

Please leave your comment to this article below.

Mathematical equations can be typed in either LaTeX formats \\[ ... \\] or $$ ... $$, or MathML format <math> ... </math>. Try the LaTeX or MathML example.

Type equation:

Preview:

Copy equation into message below

Close menu

Please click a symbol to insert it into the message box below:

Please enter the link here:

Optionally, you can enter text that should appear as linked text:

Copy link into message below

Close menu

Please enter or paste the URL to the image here (please only use links to jpg/jpeg, png and gif images):

Copy image into message below

Close menu

Type author name or keywords to filter the list of references in this group (you can add a new citation under Bibliography):

No existing citations in Discussion Group

Wikify editor is a simple editor for wiki-style mark-up. It was written by MDPI for Sciforum in 2014. The rendering of the mark-up is based on Wiky.php with some tweaks. Rendering of mathematical equations is done with MathJax. Please send us a message for support or for reporting bugs.

Close menu

Please declare any conflicts of interest you may have with this paper, financial or otherwise.

I do not have a conflict of interest

I would like to declare a conflict of interest

Display my name on the website I want to get recognition for my comment on Publons

[what’s this?]. Link your accounts here

Captcha

Renew

I accept the following conditions:

Comments must follow the standards of professional discourse and should focus on the scientific content of the article. Insulting or offensive language, personal attacks and off-topic remarks will not be permitted. Comments must be written in English. Preprints reserves the right to remove comments without notice. Readers who post comments are obliged to declare any competing interests, financial or otherwise.

Notify me about updates to this article or when a peer-reviewed version is published.

Upload a Image(max file size 2MB)

How Risky if China Moves Away from Its Zero-COVID Policy?

Abstract

Keywords

Subject

Comments (1)